Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06375681 · University of Wisconsin, Madison

Effectiveness of Cognitive Training in Older and Younger Adults

What this study is about

The proposed study will enroll 1600 participants to examine the effectiveness of cognitive training. Participants will be randomly assigned into different experimental groups and can expect to participate for up to 15 hours of research over 4 to 8 weeks.

View original scientific description

The proposed study will enroll 1600 participants to examine the effectiveness of cognitive training. Participants will be randomized into different experimental groups and can expect to participate for up to 15 hours of research over 4 to 8 weeks.

Interventions

BEHAVIORAL

Visual and / or Auditory Cognitive Tasks (1)

Seven sessions (\~45-75 minutes) of cognitive tasks in the lab. Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

BEHAVIORAL

Visual and / or Auditory Cognitive Tasks (2)

Two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab. Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

Primary outcome measures

Change in the difference between the proportion of hits minus false alarms for a given level of the N-back task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The n-Back Task is a measure of working memory. The participant is sequentially shown a series of letters and is asked to indicate whether the current letter matches the letter presented "n" items before. The n levels range between 1- and 4-back. Each level of n-back has 17-19 letters, with 5 target letters.

Change in the proportion of correctly reported sequences in the Corsi Complex task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The Corsi Complex Task is a measure of working memory. The participant is sequentially shown a series of positions from 12 possible predefined spots on the screen. Between each position, the participants is also asked to categorize a stimulus between two categories based on color and shape. The participant's task is to report the sequence of positions in order. The length of sequence can vary between 2 and 10.

Change in the proportion of correctly reported number and letter sets in the Letter-Number task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The Letter-Number Sequence Task is a measure of working memory. In each trial, the participant is presented with a sequence of alternating letters and numbers, from 2 to 10 stimuli. Participants have to report the numbers in ascending order, and the letters in alphabetical order.

Change in the difference of response time and accuracy in switch trials minus non-switch trials in the Task Switching Task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The Task Switching task is a measure of cognitive flexibility. On each trial, participants view a letter and a digit. A cue tells the participant to either categorize the letter as a consonant or vowel or else categorize the digit as even or odd. Trials can be either "non-switch trials" - in which the participant is asked to perform the same task as on the previous trial - or "switch trials" - in which the participant is asked to perform the opposite task as on the previous trial. The participant will complete 48 trials. A "switch cost" is calculated by subtracting the average response time for switch trials from the average response time for non-switch trials.

Change in the difference of response time in (i) switch trials minus non-switch trials and (ii) congruent minus incongruent trials in the Flanker Task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

In the Flanker task, the participant is asked to indicate whether the centrally presented arrow is pointing either to the left or right by pressing the left or right triangular buttons. This arrow is surrounded by 4 identical arrows, 2 to its left and 2 to its right; these are called non-target arrows. The participant is presented with two different trial types during the task, incongruent and congruent. In the congruent trials, the non-target arrows point in the same direction as the target arrow (e.g. all to the left) and in the incongruent trials they point in the opposite direction (e.g. target to the right, non-targets to the left). Switch trials are trials preceded by a trial of the opposite category (i.e. congruent preceded by incongruent or incongruent preceded by congruent).

Change in the proportion of correctly identified targets in the mixed condition of the Cancellation task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The Cancellation task is a measure of cognitive flexibility. Participants are presented with rows of 8 stimuli that can be either cats or dogs. Each cat and dog varies along its orientation, color pattern, and/or stance, giving 4 distinct cats and 4 distinct dogs. One cat and one dog are targets, and the rest are distractors. The goal of the participant is to mark as many targets as possible within each row in the allotted time (210 seconds).

Change in the proportion of correct responses on the Useful Field of View (UFOV) Task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The UFOV is a measure of visual selective attention. Participants are briefly presented with a display consisting of 24 peripheral items (3 on each of the four radial spokes and the four obliques; evenly spaced) and 1 central stimulus (a smiley with either long or short hair). One of the peripheral items is a target, while the remaining items are distractors. The participants' task is to indicate upon which of the 8 spokes the target appeared, and whether the central smiley had short or long hair. The display times vary between 16-500ms.

Change in the proportion of correct responses on the Multiple Object Tracking (MOT) Task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The MOT is a measure of visual divided attention. On each trial, participants view a series of blue and yellow smiley faces randomly moving in circular area. After a few seconds, the blue faces become yellow, indistinguishable from the distractors, while all the items keep moving on the screen. After another period of a few seconds, the items stop, and the participant is asked whether a randomly selected face was initially blue or yellow at the beginning of the trial.

Change in the response time and percentage of correct responses in the Mental Rotation Task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The mental rotation task is a measure of spatial cognition. Each trial displays two 2-D images, and the participant is asked whether the image on the right is a rotated version or a mirror-reserved and rotated version of the image on the left. The participant will complete 36 trials.

Change in the percentage of correct responses in the Paper Folding task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The Paper Folding task is a measure of mental rotation. Participants are shown 2-4 images depicting a piece of paper being folded with a hole being punched after the last fold. The participant is asked to imagine and indicate what the paper would look like unfolded. The participant will complete 10 trials.

Change in the sum of correctly solved items in Raven's Advanced Progressive Matrices task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

Raven's Advanced Progressive Matrices task is a measure of fluid intelligence. The participant is presented with a grid of elements with one of the elements missing and is asked to identify the missing element that completes the grid pattern. The participant will complete 14 trials.

Change in the sum of correctly solved items in the UC Matrix Reasoning task

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

The UC Matrix Reasoning task is a measure of fluid intelligence. The participant is presented with a grid of elements with one of the elements missing and is asked to identify the missing element that completes the grid pattern. The participant will complete 16 trials.

Change in the percentage of accuracy in the Shipley Institute of Living Scale

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

Participants will complete Part I of the Shipley Institute of Living Scale, which is a measure of vocabulary. Participants are asked to select the appropriate synonym for a target word among several alternatives for 15 words.

Change in the percentage of accuracy in the Mill-Hill Vocabulary Scale

Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

In this vocabulary task, participants are asked to select the appropriate synonym for a target word among several alternatives for 25 words.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Self-reported normal or corrected-to-normal vision
  • No known neurological impairments
  • Age within inclusion range (18-30 Years for Younger Adults and 60-85 Years for Older Adults)

Exclusion criteria

  • Physical handicap (motor or perceptual) that would impede training procedures
  • Concurrent enrollment in other cognitive training studies
  • Not being proficient enough in English that would prevent following and understanding all instructions and completing all testing sessions (typically, participants would need to have learned English before age 11; there might be some exceptions that will be decided on a case-by-case basis).
  • Unable to adhere to training schedule Additional exclusion criteria for older adults: \- Score \< 17 (out of 22) on the Telephone Montreal Cognitive Assessment (T-MoCA).

Where

  • Riverside, California
  • Boston, Massachusetts
  • Madison, Wisconsin

Collaborators

National Institute on Aging (NIA)

Related conditions & keywords

Cognitive ChangeCognitive TrainingTraining taskTesting context

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced May 29, 2026 · Source of record for eligibility and locations

📊
1 of 1600 participants interested
0% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Riverside

California

Location available
RECRUITING

Boston

Massachusetts

Location available
RECRUITING

Madison

Wisconsin

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Looking for Cognitive Change Treatment in Riverside?

Join others in California exploring innovative treatment options through clinical research

Cognitive Change Treatment Options in Riverside, California

If you're searching for Cognitive Change treatment in Riverside, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Riverside, Boston, Madison and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Cognitive Change. All study-related care is provided at no cost to participants.

Local Sites
3 locations in California
Now Enrolling
Up to 1600 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Cognitive Change?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Cognitive Change

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Cognitive Change Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06375681. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.